•  •  Dark Mode

Your Interests & Preferences

I am a...

law firm lawyer
in-house company lawyer
litigation lawyer
law student
aspiring student

Website Look & Feel

 •  •  Dark Mode
Blog Layout

Save preferences

L&L, Platinum, WG act on $100m sale of Symbiotec Pharma to consortium of PEs

A consortium of mid-market private equity firms InvAscent and Motilal Oswal PE has bought British PE firm Actis’ entire stake of around 70% in bulk-drugs maker Symbiotec Pharmalab Pvt. Ltd.


L&L Partners advised Symbiotec Pharma Lab Pvt Limited led by a team of partner William Vivian John along with managing associate Deepak Kumar and associate Tanaya Sanyal.

Update 29 May 2019: A Platinum Partners team of partner Gautam Bhat and partner Abhik Ghosh for advised Actis Private Equity, and a team of partner Ankit Majmudar and associate Aayush Kumar for InvAscent.

Wadia Ghandy advised MOPE Investment Advisors Private Limited.


Deal value: USD 100 million

This deal report is based on a firm's press release and may be only partially complete. Some firms or names of advisers may be therefore be missing.

No comments yet: share your views